机构:[1]Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China广东省人民医院[2]Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China[3]CAS Key Laboratory of Regenerative Biology, Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China[4]Bioland Laboratory Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China[5]Laboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China[6]Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China深圳市康宁医院深圳医学信息中心[7]Guangdong Provincial Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease and Guangzhou Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease, Guangzhou, China[8]Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong, China[9]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, P.R. China广东省中医院
This work was supported in part by the National Natural Science
Foundation of China (92068021, 32270574, 32150710521), the National
Key Research and Development Program of China (2018YFA0108700 and
2017YFA0105602), the Guangdong Science and Technology Project
(2020B1212060052, 2022B1212010010), and Science and Technology Projects
in Guangzhou (2023A03J0045, 2023A04J0156). Guangzhou Key Laboratory
of Biological Targeting Diagnosis and Therapy (202201020379) and
the Youth Innovation Promotion of the Chinese Academy of Sciences
(2019348) to D Li. Guangdong Cardiovascular Institute (2020XXG002), Highlevel
Hospital Construction Project (DFJHBF202110, DFJHBF202111), and
Plan on Enhancing Scientific Research in GMU.
第一作者机构:[1]Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China[3]CAS Key Laboratory of Regenerative Biology, Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China[2]Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China[7]Guangdong Provincial Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease and Guangzhou Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease, Guangzhou, China
推荐引用方式(GB/T 7714):
Zhong Hui,Zhang Ran,Li Guihuan,et al.c-JUN is a barrier in hESC to cardiomyocyte transition[J].LIFE SCIENCE ALLIANCE.2023,6(11):doi:10.26508/lsa.202302121.
APA:
Zhong Hui,Zhang Ran,Li Guihuan,Huang Ping,Zhang Yudan...&Li Dongwei.(2023).c-JUN is a barrier in hESC to cardiomyocyte transition.LIFE SCIENCE ALLIANCE,6,(11)
MLA:
Zhong Hui,et al."c-JUN is a barrier in hESC to cardiomyocyte transition".LIFE SCIENCE ALLIANCE 6..11(2023)